Funding for this research was provided by:
Eli Lilly and Company
Received: 16 December 2019
Accepted: 25 April 2020
First Online: 5 May 2020
Ethics approval and consent to participate
: All study data were accessed with protocols compliant with US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act of 1996 regulations (HIPAA). As all database used in the study are fully de-identified and compliant with the HIPPA, this study was exempted from Institutional Review Board approval.
: Not applicable, this manuscript does not contain data from any named individuals.
: LH is employed by Eli Lilly and Company. NP, DM and PC are employed by IBM Watson Health, which received funding from Eli Lilly and Company to conduct this study.